Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Addus acquires certain assets of Armada Skilled Home Health for $29M » 08:05
07/13/21
07/13
08:05
07/13/21
08:05
ADUS

Addus HomeCare

$86.21 /

+1.38 (+1.63%)

Addus HomeCare announced…

Addus HomeCare announced the signing of a definitive agreement to acquire Armada Skilled Home Health of New Mexico, Armada Hospice of New Mexico, and Armada Hospice of Santa Fe for a cash purchase price of approximately $29M. Based in Albuquerque, New Mexico, Armada currently serves an average daily census of approximately 1,100 patients for home health services and 100 patients for hospice care, with primary coverage across Bernalillo County and surrounding counties. Addus expects to close the transaction on or about August 1, following completion of all required regulatory approvals, subject to customary closing conditions. "Armada has annualized revenues of approximately $23M and we expect this transaction to be immediately accretive to our financial results," said Allison.

ShowHide Related Items >><<
ADUS Addus HomeCare
$86.21 /

+1.38 (+1.63%)

ADUS Addus HomeCare
$86.21 /

+1.38 (+1.63%)

06/17/21 Stephens
Supreme Court ruling removes overhang on ACA levered stocks, says Stephens
06/17/21 RBC Capital
RBC Capital sees no issues to justify weakness in Addus HomeCare
08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
ADUS Addus HomeCare
$86.21 /

+1.38 (+1.63%)

  • 08
    Dec
  • 13
    Aug
ADUS Addus HomeCare
$86.21 /

+1.38 (+1.63%)

Over a month ago
Conference/Events
Addus HomeCare participates in a conference call with Stephens » 13:25
06/22/21
06/22
13:25
06/22/21
13:25
ADUS

Addus HomeCare

$84.21 /

-0.01 (-0.01%)

Conference call with CEO…

Conference call with CEO Allison and CFO Pof will be held on June 22 at 2 pm hosted by Stephens.

ShowHide Related Items >><<
ADUS Addus HomeCare
$84.21 /

-0.01 (-0.01%)

ADUS Addus HomeCare
$84.21 /

-0.01 (-0.01%)

06/17/21 Stephens
Supreme Court ruling removes overhang on ACA levered stocks, says Stephens
06/17/21 RBC Capital
RBC Capital sees no issues to justify weakness in Addus HomeCare
08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
ADUS Addus HomeCare
$84.21 /

-0.01 (-0.01%)

  • 08
    Dec
  • 13
    Aug
ADUS Addus HomeCare
$84.21 /

-0.01 (-0.01%)

Conference/Events
Addus HomeCare participates in a conference call with Stephens » 04:55
06/22/21
06/22
04:55
06/22/21
04:55
ADUS

Addus HomeCare

$84.22 /

+3.49 (+4.32%)

Conference call with CEO…

Conference call with CEO Allison and CFO Pof will be held on June 22 at 2 pm hosted by Stephens.

ShowHide Related Items >><<
ADUS Addus HomeCare
$84.22 /

+3.49 (+4.32%)

ADUS Addus HomeCare
$84.22 /

+3.49 (+4.32%)

06/17/21 Stephens
Supreme Court ruling removes overhang on ACA levered stocks, says Stephens
06/17/21 RBC Capital
RBC Capital sees no issues to justify weakness in Addus HomeCare
08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
ADUS Addus HomeCare
$84.22 /

+3.49 (+4.32%)

  • 08
    Dec
  • 13
    Aug
ADUS Addus HomeCare
$84.22 /

+3.49 (+4.32%)

Recommendations
Supreme Court ruling removes overhang on ACA levered stocks, says Stephens » 13:29
06/17/21
06/17
13:29
06/17/21
13:29
MOH

Molina Healthcare

$248.50 /

+4.89 (+2.01%)

, CNC

Centene

$73.90 /

+1.2 (+1.65%)

, ADUS

Addus HomeCare

$83.81 /

-1.14 (-1.34%)

, AVAH

Aveanna

$12.53 /

+0.14 (+1.13%)

, ENSG

Ensign Group

$85.78 /

+0.65 (+0.76%)

, ANTM

Anthem

$378.78 /

+0.31 (+0.08%)

Stephens analyst Scott…

Stephens analyst Scott Fidel said the Supreme Court ruling to uphold the Affordable Care Act, or ACA, was "universally expected by investors following an abysmal performance by the red state AG's during oral arguments," but it still formally removes the SCOTUS overhang on what he sees as the ACA levered stocks. Fidel identifies Molina Healthcare (MOH), Centene (CNC), Addus HomeCare (ADUS), Aveanna (AVAH), Ensign Group (ENSG) and Anthem (ANTM) as the names most levered to the ACA among those he covers.

ShowHide Related Items >><<
MOH Molina Healthcare
$248.50 /

+4.89 (+2.01%)

ENSG Ensign Group
$85.78 /

+0.65 (+0.76%)

CNC Centene
$73.90 /

+1.2 (+1.65%)

ANTM Anthem
$378.78 /

+0.31 (+0.08%)

ADUS Addus HomeCare
$83.81 /

-1.14 (-1.34%)

MOH Molina Healthcare
$248.50 /

+4.89 (+2.01%)

05/18/21 Wells Fargo
Molina Healthcare initiated with an Underweight at Wells Fargo
04/30/21 Mizuho
Molina Healthcare price target raised to $273 from $245 at Mizuho
04/14/21 Truist
Molina Healthcare price target raised to $290 from $260 at Truist
03/30/21 Credit Suisse
Molina Healthcare initiated with an Outperform at Credit Suisse
CNC Centene
$73.90 /

+1.2 (+1.65%)

06/17/21 Truist
Centene price target raised to $90 from $80 at Truist
06/17/21 Wells Fargo
Centene price target raised to $93 from $87 at Wells Fargo
06/17/21 BMO Capital
Centene price target raised to $93 from $88 at BMO Capital
06/17/21 Mizuho
Centene price target raised to $75 from $65 at Mizuho
ADUS Addus HomeCare
$83.81 /

-1.14 (-1.34%)

06/17/21 RBC Capital
RBC Capital sees no issues to justify weakness in Addus HomeCare
08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
AVAH Aveanna
$12.53 /

+0.14 (+1.13%)

05/27/21 Barclays
Aveanna price target lowered to $19 from $20 at Barclays
05/24/21 RBC Capital
Aveanna initiated with an Outperform at RBC Capital
05/24/21 Jefferies
Aveanna initiated with a Buy at Jefferies
05/24/21 Raymond James
Aveanna initiated with a Strong Buy at Raymond James
ENSG Ensign Group
$85.78 /

+0.65 (+0.76%)

05/03/21 RBC Capital
Ensign Group price target raised to $100 from $95 at RBC Capital
04/16/21 Stephens
Humana named a new Best Idea for 2021 at Stephens
04/14/21 Truist
Ensign Group price target raised to $98 from $90 at Truist
01/05/21 Truist
Ensign Group price target raised to $82 from $64 at Truist
ANTM Anthem
$378.78 /

+0.31 (+0.08%)

06/10/21 RBC Capital
RBC Capital cuts Anthem to Sector Perform, sees few near-term catalysts
06/10/21 RBC Capital
Anthem downgraded to Sector Perform from Outperform at RBC Capital
05/21/21 Piper Sandler
Piper 'pleasantly surprised' Anthem reversed decision on Inspire therapy
05/18/21 Wells Fargo
Anthem initiated with an Overweight at Wells Fargo
MOH Molina Healthcare
$248.50 /

+4.89 (+2.01%)

ENSG Ensign Group
$85.78 /

+0.65 (+0.76%)

CNC Centene
$73.90 /

+1.2 (+1.65%)

ANTM Anthem
$378.78 /

+0.31 (+0.08%)

ADUS Addus HomeCare
$83.81 /

-1.14 (-1.34%)

  • 29
    Apr
  • 08
    Dec
  • 13
    Aug
CNC Centene
$73.90 /

+1.2 (+1.65%)

AVAH Aveanna
$12.53 /

+0.14 (+1.13%)

ANTM Anthem
$378.78 /

+0.31 (+0.08%)

MOH Molina Healthcare
$248.50 /

+4.89 (+2.01%)

CNC Centene
$73.90 /

+1.2 (+1.65%)

AVAH Aveanna
$12.53 /

+0.14 (+1.13%)

ANTM Anthem
$378.78 /

+0.31 (+0.08%)

ADUS Addus HomeCare
$83.81 /

-1.14 (-1.34%)

CNC Centene
$73.90 /

+1.2 (+1.65%)

AVAH Aveanna
$12.53 /

+0.14 (+1.13%)

ANTM Anthem
$378.78 /

+0.31 (+0.08%)

Recommendations
RBC Capital sees no issues to justify weakness in Addus HomeCare » 08:11
06/17/21
06/17
08:11
06/17/21
08:11
ADUS

Addus HomeCare

$84.41 /

-3.72 (-4.22%)

RBC Capital analyst Frank…

RBC Capital analyst Frank Morgan keeps his Outperform rating and $136 price target, stating that while the stock has dipped over the past week, he sees no issues to justify the weakness outside of investor preference to move away from higher-multiple names. Morgan adds that business trends are consistent with management expectations, and he does not see any specific payor news related to New York or Illinois.

ShowHide Related Items >><<
ADUS Addus HomeCare
$84.41 /

-3.72 (-4.22%)

ADUS Addus HomeCare
$84.41 /

-3.72 (-4.22%)

08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
06/17/20 Baird
Addus HomeCare price target raised to $100 from $96 at Baird
ADUS Addus HomeCare
$84.41 /

-3.72 (-4.22%)

  • 08
    Dec
  • 13
    Aug
ADUS Addus HomeCare
$84.41 /

-3.72 (-4.22%)

Conference/Events
Addus HomeCare participates in a conference call with Stephens » 13:26
06/14/21
06/14
13:26
06/14/21
13:26
ADUS

Addus HomeCare

$91.31 /

+0.64 (+0.71%)

Conference call with CEO…

Conference call with CEO Allison and CFO Pof will be held on June 22 at 2 pm hosted by Stephens.

ShowHide Related Items >><<
ADUS Addus HomeCare
$91.31 /

+0.64 (+0.71%)

ADUS Addus HomeCare
$91.31 /

+0.64 (+0.71%)

08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
06/17/20 Baird
Addus HomeCare price target raised to $100 from $96 at Baird
ADUS Addus HomeCare
$91.31 /

+0.64 (+0.71%)

  • 08
    Dec
  • 13
    Aug
ADUS Addus HomeCare
$91.31 /

+0.64 (+0.71%)

Hot Stocks
Addus HomeCare announces Robby Stevenson as Chief Human Resource Officer » 08:09
06/14/21
06/14
08:09
06/14/21
08:09
ADUS

Addus HomeCare

$90.89 /

-1.33 (-1.44%)

Addus HomeCare announced…

Addus HomeCare announced that Laurie Manning retired from her position as Executive Vice President and Chief Human Resource Officer, effective June 11. Robby Stevenson, Senior Vice President of Human Resources, has been promoted to Executive Vice President and Chief Human Resource Officer and will assume leadership in that area.

ShowHide Related Items >><<
ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
06/17/20 Baird
Addus HomeCare price target raised to $100 from $96 at Baird
ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

  • 08
    Dec
  • 13
    Aug
ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

Conference/Events
Jefferies to hold a virtual conference » 04:55
06/04/21
06/04
04:55
06/04/21
04:55
VERU

Veru

$8.84 /

-0.29 (-3.18%)

, CABA

Cabaletta Bio

$10.20 /

-0.05 (-0.49%)

, ICLR

Icon

$220.43 /

-0.04 (-0.02%)

, PRTA

Prothena

$28.65 /

+0.48 (+1.70%)

, SHC

Sotera Health

$24.47 /

+0.04 (+0.16%)

, PHAT

Phathom Pharmaceuticals

$33.20 /

+0.41 (+1.25%)

, CCCC

C4 Therapeutics

$38.13 /

+0.2 (+0.53%)

, LABP

Landos Biopharma

$11.81 /

+0.53 (+4.70%)

, TWST

Twist Bioscience

$96.05 /

-6.22 (-6.08%)

, LVTX

Lava Therapeutics

$11.04 /

+0.05 (+0.45%)

, ACRS

Aclaris Therapeutics

$21.93 /

+0.28 (+1.29%)

, CRSP

Crispr Therapeutics

$109.92 /

-4.79 (-4.18%)

, GILD

Gilead

$66.48 /

+0.44 (+0.67%)

, A

Agilent

$136.40 /

-0.175 (-0.13%)

, ICAD

iCAD

$17.10 /

+0.38 (+2.27%)

, CRIS

Curis

$14.46 /

+0.02 (+0.14%)

, ADUS

Addus HomeCare

$94.40 /

-0.53 (-0.56%)

, VOR

Vor Biopharma

$19.95 /

+0.4 (+2.05%)

, VCNX

Vaccinex

$2.33 /

-0.14 (-5.67%)

2021 Global Healthcare…

2021 Global Healthcare Virtual Conference to be held on June 1-4.

ShowHide Related Items >><<
VOR Vor Biopharma
$19.95 /

+0.4 (+2.05%)

VERU Veru
$8.84 /

-0.29 (-3.18%)

VCNX Vaccinex
$2.33 /

-0.14 (-5.67%)

TWST Twist Bioscience
$96.05 /

-6.22 (-6.08%)

SHC Sotera Health
$24.47 /

+0.04 (+0.16%)

PRTA Prothena
$28.65 /

+0.48 (+1.70%)

PHAT Phathom Pharmaceuticals
$33.20 /

+0.41 (+1.25%)

LVTX Lava Therapeutics
$11.04 /

+0.05 (+0.45%)

LABP Landos Biopharma
$11.81 /

+0.53 (+4.70%)

ICLR Icon
$220.43 /

-0.04 (-0.02%)

ICAD iCAD
$17.10 /

+0.38 (+2.27%)

GILD Gilead
$66.48 /

+0.44 (+0.67%)

CRSP Crispr Therapeutics
$109.92 /

-4.79 (-4.18%)

CRIS Curis
$14.46 /

+0.02 (+0.14%)

CCCC C4 Therapeutics
$38.13 /

+0.2 (+0.53%)

CABA Cabaletta Bio
$10.20 /

-0.05 (-0.49%)

ADUS Addus HomeCare
$94.40 /

-0.53 (-0.56%)

ACRS Aclaris Therapeutics
$21.93 /

+0.28 (+1.29%)

A Agilent
$136.40 /

-0.175 (-0.13%)

VERU Veru
$8.84 /

-0.29 (-3.18%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
CABA Cabaletta Bio
$10.20 /

-0.05 (-0.49%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
ICLR Icon
$220.43 /

-0.04 (-0.02%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
PRTA Prothena
$28.65 /

+0.48 (+1.70%)

06/01/21 Oppenheimer
Prothena price target raised to $45 from $40 at Oppenheimer
05/26/21
Fly Intel: Top five analyst initiations
05/26/21 Citi
Prothena initiated with a Buy at Citi
05/12/21 Oppenheimer
Prothena price target raised to $40 from $35 at Oppenheimer
SHC Sotera Health
$24.47 /

+0.04 (+0.16%)

05/14/21 Barclays
Sotera Health price target lowered to $29 from $35 at Barclays
05/14/21 Citi
Sotera Health selloff brings attractive entry point, says Citi
03/02/21 Barclays
Sotera Health initiated with an Overweight at Barclays
03/02/21 Barclays
Sotera Health initiated with an Overweight at Barclays
PHAT Phathom Pharmaceuticals
$33.20 /

+0.41 (+1.25%)

05/12/21 Goldman Sachs
Phathom Pharmaceuticals upgraded to Neutral from Sell at Goldman Sachs
02/17/21 BMO Capital
Phathom Pharmaceuticals initiated with an Outperform at BMO Capital
02/02/21 Guggenheim
Phathom Pharmaceuticals initiated with a Buy at Guggenheim
01/28/21
Fly Intel: Top five analyst initiations
CCCC C4 Therapeutics
$38.13 /

+0.2 (+0.53%)

03/31/21 BMO Capital
C4 Therapeutics initiated with an Outperform at BMO Capital
12/08/20 BMO Capital
C4 Therapeutics price target raised to $45 from $33 at BMO Capital
11/24/20 Morgan Stanley
Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley
10/28/20 UBS
C4 Therapeutics initiated with a Buy at UBS
LABP Landos Biopharma
$11.81 /

+0.53 (+4.70%)

03/01/21 Jefferies
Landos Biopharma initiated with a Buy at Jefferies
03/01/21 JPMorgan
Landos Biopharma initiated with a Neutral at JPMorgan
03/01/21 Raymond James
Landos Biopharma initiated with an Outperform at Raymond James
03/01/21 SVB Leerink
Landos Biopharma initiated with an Outperform at SVB Leerink
TWST Twist Bioscience
$96.05 /

-6.22 (-6.08%)

05/11/21 Piper Sandler
Twist Bioscience recent weakness a buying opportunity, says Piper Sandler
04/12/21
Fly Intel: Top five analyst initiations
04/12/21 Piper Sandler
Twist Bioscience initiated with an Overweight at Piper Sandler
02/05/21 Baird
Twist Bioscience price target raised to $200 from $125 at Baird
LVTX Lava Therapeutics
$11.04 /

+0.05 (+0.45%)

04/19/21 SVB Leerink
SVB Leerink bullish on Lava Therapeutics, initiates with an Outperform
04/19/21 JPMorgan
Lava Therapeutics initiated with an Overweight at JPMorgan
04/19/21 Jefferies
Lava Therapeutics initiated with a Buy at Jefferies
04/19/21 SVB Leerink
Lava Therapeutics initiated with an Outperform at SVB Leerink
ACRS Aclaris Therapeutics
$21.93 /

+0.28 (+1.29%)

04/21/21 H.C. Wainwright
Aclaris Therapeutics initiated with a Buy at H.C. Wainwright
03/04/21 SVB Leerink
Aclaris Therapeutics price target raised to $26 from $21 at SVB Leerink
02/02/21 Cantor Fitzgerald
Aclaris Therapeutics price target raised to $30 from $15 at Cantor Fitzgerald
01/19/21 William Blair
Aclaris has potential in range of 'blockbuster indications,' says William Blair
CRSP Crispr Therapeutics
$109.92 /

-4.79 (-4.18%)

05/13/21 Evercore ISI
Crispr Therapeutics upgraded to Outperform from In Line at Evercore ISI
04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
04/21/21 Jefferies
Crispr Therapeutics upgraded to Buy from Hold at Jefferies
GILD Gilead
$66.48 /

+0.44 (+0.67%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
A Agilent
$136.40 /

-0.175 (-0.13%)

05/26/21 SVB Leerink
Agilent price target raised to $145 from $140 at SVB Leerink
05/26/21 KeyBanc
Agilent price target raised to $157 from $148 at KeyBanc
05/26/21 Wells Fargo
Agilent price target raised to $150 from $140 at Wells Fargo
05/26/21 Baird
Agilent price target raised to $144 from $137 at Baird
ICAD iCAD
$17.10 /

+0.38 (+2.27%)

04/22/21 Guggenheim
iCAD initiated with a Buy at Guggenheim
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
02/26/21 B. Riley
iCAD price target raised to $23 from $18 at B. Riley Securities
CRIS Curis
$14.46 /

+0.02 (+0.14%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
ADUS Addus HomeCare
$94.40 /

-0.53 (-0.56%)

08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
06/17/20 Baird
Addus HomeCare price target raised to $100 from $96 at Baird
VOR Vor Biopharma
$19.95 /

+0.4 (+2.05%)

03/25/21 B. Riley
Vor Biopharma initiated with a Buy at B. Riley Securities
03/02/21 Evercore ISI
Vor Biopharma initiated with an Outperform at Evercore ISI
03/02/21 Stifel
Vor Biopharma initiated with a Buy at Stifel
03/02/21 Goldman Sachs
Vor Biopharma initiated with a Sell at Goldman Sachs
VCNX Vaccinex
$2.33 /

-0.14 (-5.67%)

09/25/20 Oppenheimer
Vaccinex price target lowered to $7 from $22 at Oppenheimer
09/22/20 BTIG
Vaccinex downgraded to Neutral from Buy at BTIG
VOR Vor Biopharma
$19.95 /

+0.4 (+2.05%)

VERU Veru
$8.84 /

-0.29 (-3.18%)

VCNX Vaccinex
$2.33 /

-0.14 (-5.67%)

TWST Twist Bioscience
$96.05 /

-6.22 (-6.08%)

SHC Sotera Health
$24.47 /

+0.04 (+0.16%)

PRTA Prothena
$28.65 /

+0.48 (+1.70%)

PHAT Phathom Pharmaceuticals
$33.20 /

+0.41 (+1.25%)

LVTX Lava Therapeutics
$11.04 /

+0.05 (+0.45%)

LABP Landos Biopharma
$11.81 /

+0.53 (+4.70%)

ICLR Icon
$220.43 /

-0.04 (-0.02%)

ICAD iCAD
$17.10 /

+0.38 (+2.27%)

GILD Gilead
$66.48 /

+0.44 (+0.67%)

CRSP Crispr Therapeutics
$109.92 /

-4.79 (-4.18%)

CRIS Curis
$14.46 /

+0.02 (+0.14%)

CABA Cabaletta Bio
$10.20 /

-0.05 (-0.49%)

ADUS Addus HomeCare
$94.40 /

-0.53 (-0.56%)

ACRS Aclaris Therapeutics
$21.93 /

+0.28 (+1.29%)

A Agilent
$136.40 /

-0.175 (-0.13%)

  • 24
    Mar
  • 25
    Mar
  • 18
    Mar
  • 03
    Mar
  • 18
    Feb
  • 05
    Feb
  • 04
    Feb
  • 20
    Jan
  • 17
    Dec
  • 09
    Dec
  • 08
    Dec
  • 03
    Dec
  • 20
    Nov
  • 02
    Oct
  • 13
    Aug
  • 01
    Jul
ICLR Icon
$220.43 /

-0.04 (-0.02%)

GILD Gilead
$66.48 /

+0.44 (+0.67%)

VERU Veru
$8.84 /

-0.29 (-3.18%)

TWST Twist Bioscience
$96.05 /

-6.22 (-6.08%)

PRTA Prothena
$28.65 /

+0.48 (+1.70%)

PHAT Phathom Pharmaceuticals
$33.20 /

+0.41 (+1.25%)

LVTX Lava Therapeutics
$11.04 /

+0.05 (+0.45%)

LABP Landos Biopharma
$11.81 /

+0.53 (+4.70%)

ICLR Icon
$220.43 /

-0.04 (-0.02%)

ICAD iCAD
$17.10 /

+0.38 (+2.27%)

GILD Gilead
$66.48 /

+0.44 (+0.67%)

CRSP Crispr Therapeutics
$109.92 /

-4.79 (-4.18%)

CRIS Curis
$14.46 /

+0.02 (+0.14%)

ADUS Addus HomeCare
$94.40 /

-0.53 (-0.56%)

ACRS Aclaris Therapeutics
$21.93 /

+0.28 (+1.29%)

A Agilent
$136.40 /

-0.175 (-0.13%)

VERU Veru
$8.84 /

-0.29 (-3.18%)

VCNX Vaccinex
$2.33 /

-0.14 (-5.67%)

SHC Sotera Health
$24.47 /

+0.04 (+0.16%)

GILD Gilead
$66.48 /

+0.44 (+0.67%)

CRSP Crispr Therapeutics
$109.92 /

-4.79 (-4.18%)

CRIS Curis
$14.46 /

+0.02 (+0.14%)

CCCC C4 Therapeutics
$38.13 /

+0.2 (+0.53%)

CABA Cabaletta Bio
$10.20 /

-0.05 (-0.49%)

A Agilent
$136.40 /

-0.175 (-0.13%)

Conference/Events
Jefferies to hold a virtual conference » 04:55
06/03/21
06/03
04:55
06/03/21
04:55
VERU

Veru

$9.12 /

+0.25 (+2.82%)

, CABA

Cabaletta Bio

$10.29 /

-0.77 (-6.96%)

, ICLR

Icon

$220.53 /

-2.16 (-0.97%)

, PRTA

Prothena

$28.17 /

+0.83 (+3.04%)

, SHC

Sotera Health

$24.44 /

+0.13 (+0.53%)

, PHAT

Phathom Pharmaceuticals

$32.70 /

-3.57 (-9.84%)

, CCCC

C4 Therapeutics

$38.02 /

+0.51 (+1.36%)

, LABP

Landos Biopharma

$11.32 /

+0.22 (+1.98%)

, TWST

Twist Bioscience

$102.42 /

-3.45 (-3.26%)

, LVTX

Lava Therapeutics

$10.90 /

-0.12 (-1.09%)

, ACRS

Aclaris Therapeutics

$21.76 /

-1.88 (-7.95%)

, CRSP

Crispr Therapeutics

$114.73 /

-1.02 (-0.88%)

, GILD

Gilead

$66.04 /

+0.73 (+1.12%)

, A

Agilent

$136.58 /

-0.665 (-0.48%)

, ICAD

iCAD

$16.72 /

+0.09 (+0.54%)

, CRIS

Curis

$14.44 /

+0.01 (+0.07%)

, ADUS

Addus HomeCare

$95.26 /

+0.1 (+0.11%)

, VOR

Vor Biopharma

$19.72 /

-0.8 (-3.90%)

, VCNX

Vaccinex

$2.47 /

+0.03 (+1.23%)

2021 Global Healthcare…

2021 Global Healthcare Virtual Conference to be held on June 1-4.

ShowHide Related Items >><<
VOR Vor Biopharma
$19.72 /

-0.8 (-3.90%)

VERU Veru
$9.12 /

+0.25 (+2.82%)

VCNX Vaccinex
$2.47 /

+0.03 (+1.23%)

TWST Twist Bioscience
$102.42 /

-3.45 (-3.26%)

SHC Sotera Health
$24.44 /

+0.13 (+0.53%)

PRTA Prothena
$28.17 /

+0.83 (+3.04%)

PHAT Phathom Pharmaceuticals
$32.70 /

-3.57 (-9.84%)

LVTX Lava Therapeutics
$10.90 /

-0.12 (-1.09%)

LABP Landos Biopharma
$11.32 /

+0.22 (+1.98%)

ICLR Icon
$220.53 /

-2.16 (-0.97%)

ICAD iCAD
$16.72 /

+0.09 (+0.54%)

GILD Gilead
$66.04 /

+0.73 (+1.12%)

CRSP Crispr Therapeutics
$114.73 /

-1.02 (-0.88%)

CRIS Curis
$14.44 /

+0.01 (+0.07%)

CCCC C4 Therapeutics
$38.02 /

+0.51 (+1.36%)

CABA Cabaletta Bio
$10.29 /

-0.77 (-6.96%)

ADUS Addus HomeCare
$95.26 /

+0.1 (+0.11%)

ACRS Aclaris Therapeutics
$21.76 /

-1.88 (-7.95%)

A Agilent
$136.58 /

-0.665 (-0.48%)

VERU Veru
$9.12 /

+0.25 (+2.82%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
CABA Cabaletta Bio
$10.29 /

-0.77 (-6.96%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
ICLR Icon
$220.53 /

-2.16 (-0.97%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
PRTA Prothena
$28.17 /

+0.83 (+3.04%)

06/01/21 Oppenheimer
Prothena price target raised to $45 from $40 at Oppenheimer
05/26/21
Fly Intel: Top five analyst initiations
05/26/21 Citi
Prothena initiated with a Buy at Citi
05/12/21 Oppenheimer
Prothena price target raised to $40 from $35 at Oppenheimer
SHC Sotera Health
$24.44 /

+0.13 (+0.53%)

05/14/21 Barclays
Sotera Health price target lowered to $29 from $35 at Barclays
05/14/21 Citi
Sotera Health selloff brings attractive entry point, says Citi
03/02/21 Barclays
Sotera Health initiated with an Overweight at Barclays
03/02/21 Barclays
Sotera Health initiated with an Overweight at Barclays
PHAT Phathom Pharmaceuticals
$32.70 /

-3.57 (-9.84%)

05/12/21 Goldman Sachs
Phathom Pharmaceuticals upgraded to Neutral from Sell at Goldman Sachs
02/17/21 BMO Capital
Phathom Pharmaceuticals initiated with an Outperform at BMO Capital
02/02/21 Guggenheim
Phathom Pharmaceuticals initiated with a Buy at Guggenheim
01/28/21
Fly Intel: Top five analyst initiations
CCCC C4 Therapeutics
$38.02 /

+0.51 (+1.36%)

03/31/21 BMO Capital
C4 Therapeutics initiated with an Outperform at BMO Capital
12/08/20 BMO Capital
C4 Therapeutics price target raised to $45 from $33 at BMO Capital
11/24/20 Morgan Stanley
Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley
10/28/20 UBS
C4 Therapeutics initiated with a Buy at UBS
LABP Landos Biopharma
$11.32 /

+0.22 (+1.98%)

03/01/21 Jefferies
Landos Biopharma initiated with a Buy at Jefferies
03/01/21 JPMorgan
Landos Biopharma initiated with a Neutral at JPMorgan
03/01/21 Raymond James
Landos Biopharma initiated with an Outperform at Raymond James
03/01/21 SVB Leerink
Landos Biopharma initiated with an Outperform at SVB Leerink
TWST Twist Bioscience
$102.42 /

-3.45 (-3.26%)

05/11/21 Piper Sandler
Twist Bioscience recent weakness a buying opportunity, says Piper Sandler
04/12/21
Fly Intel: Top five analyst initiations
04/12/21 Piper Sandler
Twist Bioscience initiated with an Overweight at Piper Sandler
02/05/21 Baird
Twist Bioscience price target raised to $200 from $125 at Baird
LVTX Lava Therapeutics
$10.90 /

-0.12 (-1.09%)

04/19/21 SVB Leerink
SVB Leerink bullish on Lava Therapeutics, initiates with an Outperform
04/19/21 JPMorgan
Lava Therapeutics initiated with an Overweight at JPMorgan
04/19/21 Jefferies
Lava Therapeutics initiated with a Buy at Jefferies
04/19/21 SVB Leerink
Lava Therapeutics initiated with an Outperform at SVB Leerink
ACRS Aclaris Therapeutics
$21.76 /

-1.88 (-7.95%)

04/21/21 H.C. Wainwright
Aclaris Therapeutics initiated with a Buy at H.C. Wainwright
03/04/21 SVB Leerink
Aclaris Therapeutics price target raised to $26 from $21 at SVB Leerink
02/02/21 Cantor Fitzgerald
Aclaris Therapeutics price target raised to $30 from $15 at Cantor Fitzgerald
01/19/21 William Blair
Aclaris has potential in range of 'blockbuster indications,' says William Blair
CRSP Crispr Therapeutics
$114.73 /

-1.02 (-0.88%)

05/13/21 Evercore ISI
Crispr Therapeutics upgraded to Outperform from In Line at Evercore ISI
04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
04/21/21 Jefferies
Crispr Therapeutics upgraded to Buy from Hold at Jefferies
GILD Gilead
$66.04 /

+0.73 (+1.12%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
A Agilent
$136.58 /

-0.665 (-0.48%)

05/26/21 SVB Leerink
Agilent price target raised to $145 from $140 at SVB Leerink
05/26/21 KeyBanc
Agilent price target raised to $157 from $148 at KeyBanc
05/26/21 Wells Fargo
Agilent price target raised to $150 from $140 at Wells Fargo
05/26/21 Baird
Agilent price target raised to $144 from $137 at Baird
ICAD iCAD
$16.72 /

+0.09 (+0.54%)

04/22/21 Guggenheim
iCAD initiated with a Buy at Guggenheim
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
02/26/21 B. Riley
iCAD price target raised to $23 from $18 at B. Riley Securities
CRIS Curis
$14.44 /

+0.01 (+0.07%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
ADUS Addus HomeCare
$95.26 /

+0.1 (+0.11%)

08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
06/17/20 Baird
Addus HomeCare price target raised to $100 from $96 at Baird
VOR Vor Biopharma
$19.72 /

-0.8 (-3.90%)

03/25/21 B. Riley
Vor Biopharma initiated with a Buy at B. Riley Securities
03/02/21 Evercore ISI
Vor Biopharma initiated with an Outperform at Evercore ISI
03/02/21 Stifel
Vor Biopharma initiated with a Buy at Stifel
03/02/21 Goldman Sachs
Vor Biopharma initiated with a Sell at Goldman Sachs
VCNX Vaccinex
$2.47 /

+0.03 (+1.23%)

09/25/20 Oppenheimer
Vaccinex price target lowered to $7 from $22 at Oppenheimer
09/22/20 BTIG
Vaccinex downgraded to Neutral from Buy at BTIG
VOR Vor Biopharma
$19.72 /

-0.8 (-3.90%)

VERU Veru
$9.12 /

+0.25 (+2.82%)

VCNX Vaccinex
$2.47 /

+0.03 (+1.23%)

TWST Twist Bioscience
$102.42 /

-3.45 (-3.26%)

SHC Sotera Health
$24.44 /

+0.13 (+0.53%)

PRTA Prothena
$28.17 /

+0.83 (+3.04%)

PHAT Phathom Pharmaceuticals
$32.70 /

-3.57 (-9.84%)

LVTX Lava Therapeutics
$10.90 /

-0.12 (-1.09%)

LABP Landos Biopharma
$11.32 /

+0.22 (+1.98%)

ICLR Icon
$220.53 /

-2.16 (-0.97%)

ICAD iCAD
$16.72 /

+0.09 (+0.54%)

GILD Gilead
$66.04 /

+0.73 (+1.12%)

CRSP Crispr Therapeutics
$114.73 /

-1.02 (-0.88%)

CRIS Curis
$14.44 /

+0.01 (+0.07%)

CABA Cabaletta Bio
$10.29 /

-0.77 (-6.96%)

ADUS Addus HomeCare
$95.26 /

+0.1 (+0.11%)

ACRS Aclaris Therapeutics
$21.76 /

-1.88 (-7.95%)

A Agilent
$136.58 /

-0.665 (-0.48%)

  • 24
    Mar
  • 25
    Mar
  • 18
    Mar
  • 03
    Mar
  • 18
    Feb
  • 05
    Feb
  • 04
    Feb
  • 20
    Jan
  • 17
    Dec
  • 09
    Dec
  • 08
    Dec
  • 03
    Dec
  • 20
    Nov
  • 02
    Oct
  • 13
    Aug
  • 01
    Jul
  • 04
    Jun
ICLR Icon
$220.53 /

-2.16 (-0.97%)

GILD Gilead
$66.04 /

+0.73 (+1.12%)

VERU Veru
$9.12 /

+0.25 (+2.82%)

TWST Twist Bioscience
$102.42 /

-3.45 (-3.26%)

PRTA Prothena
$28.17 /

+0.83 (+3.04%)

PHAT Phathom Pharmaceuticals
$32.70 /

-3.57 (-9.84%)

LVTX Lava Therapeutics
$10.90 /

-0.12 (-1.09%)

LABP Landos Biopharma
$11.32 /

+0.22 (+1.98%)

ICLR Icon
$220.53 /

-2.16 (-0.97%)

ICAD iCAD
$16.72 /

+0.09 (+0.54%)

GILD Gilead
$66.04 /

+0.73 (+1.12%)

CRSP Crispr Therapeutics
$114.73 /

-1.02 (-0.88%)

CRIS Curis
$14.44 /

+0.01 (+0.07%)

ADUS Addus HomeCare
$95.26 /

+0.1 (+0.11%)

ACRS Aclaris Therapeutics
$21.76 /

-1.88 (-7.95%)

A Agilent
$136.58 /

-0.665 (-0.48%)

VERU Veru
$9.12 /

+0.25 (+2.82%)

VCNX Vaccinex
$2.47 /

+0.03 (+1.23%)

SHC Sotera Health
$24.44 /

+0.13 (+0.53%)

GILD Gilead
$66.04 /

+0.73 (+1.12%)

CRSP Crispr Therapeutics
$114.73 /

-1.02 (-0.88%)

CRIS Curis
$14.44 /

+0.01 (+0.07%)

CCCC C4 Therapeutics
$38.02 /

+0.51 (+1.36%)

CABA Cabaletta Bio
$10.29 /

-0.77 (-6.96%)

A Agilent
$136.58 /

-0.665 (-0.48%)

Conference/Events
Jefferies to hold a virtual conference » 04:55
06/02/21
06/02
04:55
06/02/21
04:55
VERU

Veru

$8.87 /

+0.035 (+0.40%)

, CABA

Cabaletta Bio

$11.06 /

-0.34 (-2.98%)

, ICLR

Icon

$222.66 /

-1.23 (-0.55%)

, PRTA

Prothena

$27.44 /

-1.75 (-6.00%)

, SHC

Sotera Health

$24.31 /

+0.19 (+0.79%)

, PHAT

Phathom Pharmaceuticals

$35.93 /

+0.755 (+2.15%)

, CCCC

C4 Therapeutics

$37.38 /

+0.57 (+1.55%)

, LABP

Landos Biopharma

$11.10 /

+0.1 (+0.91%)

, TWST

Twist Bioscience

$105.85 /

-1.56 (-1.45%)

, LVTX

Lava Therapeutics

$11.00 /

-0.28 (-2.48%)

, ACRS

Aclaris Therapeutics

$23.64 /

+1.37 (+6.15%)

, CRSP

Crispr Therapeutics

$115.72 /

-2.52 (-2.13%)

, GILD

Gilead

$65.31 /

-0.8 (-1.21%)

, A

Agilent

$137.24 /

-0.9 (-0.65%)

, ICAD

iCAD

$16.64 /

+0.18 (+1.09%)

, CRIS

Curis

$14.43 /

+0.05 (+0.35%)

, ADUS

Addus HomeCare

$95.64 /

-0.51 (-0.53%)

, VOR

Vor Biopharma

$20.25 /

-0.68 (-3.25%)

, VCNX

Vaccinex

$2.44 /

+0.08 (+3.39%)

2021 Global Healthcare…

2021 Global Healthcare Virtual Conference to be held on June 1-4.

ShowHide Related Items >><<
VOR Vor Biopharma
$20.25 /

-0.68 (-3.25%)

VERU Veru
$8.87 /

+0.035 (+0.40%)

VCNX Vaccinex
$2.44 /

+0.08 (+3.39%)

TWST Twist Bioscience
$105.85 /

-1.56 (-1.45%)

SHC Sotera Health
$24.31 /

+0.19 (+0.79%)

PRTA Prothena
$27.44 /

-1.75 (-6.00%)

PHAT Phathom Pharmaceuticals
$35.93 /

+0.755 (+2.15%)

LVTX Lava Therapeutics
$11.00 /

-0.28 (-2.48%)

LABP Landos Biopharma
$11.10 /

+0.1 (+0.91%)

ICLR Icon
$222.66 /

-1.23 (-0.55%)

ICAD iCAD
$16.64 /

+0.18 (+1.09%)

GILD Gilead
$65.31 /

-0.8 (-1.21%)

CRSP Crispr Therapeutics
$115.72 /

-2.52 (-2.13%)

CRIS Curis
$14.43 /

+0.05 (+0.35%)

CCCC C4 Therapeutics
$37.38 /

+0.57 (+1.55%)

CABA Cabaletta Bio
$11.06 /

-0.34 (-2.98%)

ADUS Addus HomeCare
$95.64 /

-0.51 (-0.53%)

ACRS Aclaris Therapeutics
$23.64 /

+1.37 (+6.15%)

A Agilent
$137.24 /

-0.9 (-0.65%)

VERU Veru
$8.87 /

+0.035 (+0.40%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
CABA Cabaletta Bio
$11.06 /

-0.34 (-2.98%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
ICLR Icon
$222.66 /

-1.23 (-0.55%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
PRTA Prothena
$27.44 /

-1.75 (-6.00%)

06/01/21 Oppenheimer
Prothena price target raised to $45 from $40 at Oppenheimer
05/26/21
Fly Intel: Top five analyst initiations
05/26/21 Citi
Prothena initiated with a Buy at Citi
05/12/21 Oppenheimer
Prothena price target raised to $40 from $35 at Oppenheimer
SHC Sotera Health
$24.31 /

+0.19 (+0.79%)

05/14/21 Barclays
Sotera Health price target lowered to $29 from $35 at Barclays
05/14/21 Citi
Sotera Health selloff brings attractive entry point, says Citi
03/02/21 Barclays
Sotera Health initiated with an Overweight at Barclays
03/02/21 Barclays
Sotera Health initiated with an Overweight at Barclays
PHAT Phathom Pharmaceuticals
$35.93 /

+0.755 (+2.15%)

05/12/21 Goldman Sachs
Phathom Pharmaceuticals upgraded to Neutral from Sell at Goldman Sachs
02/17/21 BMO Capital
Phathom Pharmaceuticals initiated with an Outperform at BMO Capital
02/02/21 Guggenheim
Phathom Pharmaceuticals initiated with a Buy at Guggenheim
01/28/21
Fly Intel: Top five analyst initiations
CCCC C4 Therapeutics
$37.38 /

+0.57 (+1.55%)

03/31/21 BMO Capital
C4 Therapeutics initiated with an Outperform at BMO Capital
12/08/20 BMO Capital
C4 Therapeutics price target raised to $45 from $33 at BMO Capital
11/24/20 Morgan Stanley
Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley
10/28/20 UBS
C4 Therapeutics initiated with a Buy at UBS
LABP Landos Biopharma
$11.10 /

+0.1 (+0.91%)

03/01/21 Jefferies
Landos Biopharma initiated with a Buy at Jefferies
03/01/21 JPMorgan
Landos Biopharma initiated with a Neutral at JPMorgan
03/01/21 Raymond James
Landos Biopharma initiated with an Outperform at Raymond James
03/01/21 SVB Leerink
Landos Biopharma initiated with an Outperform at SVB Leerink
TWST Twist Bioscience
$105.85 /

-1.56 (-1.45%)

05/11/21 Piper Sandler
Twist Bioscience recent weakness a buying opportunity, says Piper Sandler
04/12/21
Fly Intel: Top five analyst initiations
04/12/21 Piper Sandler
Twist Bioscience initiated with an Overweight at Piper Sandler
02/05/21 Baird
Twist Bioscience price target raised to $200 from $125 at Baird
LVTX Lava Therapeutics
$11.00 /

-0.28 (-2.48%)

04/19/21 SVB Leerink
SVB Leerink bullish on Lava Therapeutics, initiates with an Outperform
04/19/21 JPMorgan
Lava Therapeutics initiated with an Overweight at JPMorgan
04/19/21 Jefferies
Lava Therapeutics initiated with a Buy at Jefferies
04/19/21 SVB Leerink
Lava Therapeutics initiated with an Outperform at SVB Leerink
ACRS Aclaris Therapeutics
$23.64 /

+1.37 (+6.15%)

04/21/21 H.C. Wainwright
Aclaris Therapeutics initiated with a Buy at H.C. Wainwright
03/04/21 SVB Leerink
Aclaris Therapeutics price target raised to $26 from $21 at SVB Leerink
02/02/21 Cantor Fitzgerald
Aclaris Therapeutics price target raised to $30 from $15 at Cantor Fitzgerald
01/19/21 William Blair
Aclaris has potential in range of 'blockbuster indications,' says William Blair
CRSP Crispr Therapeutics
$115.72 /

-2.52 (-2.13%)

05/13/21 Evercore ISI
Crispr Therapeutics upgraded to Outperform from In Line at Evercore ISI
04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
04/21/21 Jefferies
Crispr Therapeutics upgraded to Buy from Hold at Jefferies
GILD Gilead
$65.31 /

-0.8 (-1.21%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
A Agilent
$137.24 /

-0.9 (-0.65%)

05/26/21 SVB Leerink
Agilent price target raised to $145 from $140 at SVB Leerink
05/26/21 KeyBanc
Agilent price target raised to $157 from $148 at KeyBanc
05/26/21 Wells Fargo
Agilent price target raised to $150 from $140 at Wells Fargo
05/26/21 Baird
Agilent price target raised to $144 from $137 at Baird
ICAD iCAD
$16.64 /

+0.18 (+1.09%)

04/22/21 Guggenheim
iCAD initiated with a Buy at Guggenheim
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
02/26/21 B. Riley
iCAD price target raised to $23 from $18 at B. Riley Securities
CRIS Curis
$14.43 /

+0.05 (+0.35%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
ADUS Addus HomeCare
$95.64 /

-0.51 (-0.53%)

08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
06/17/20 Baird
Addus HomeCare price target raised to $100 from $96 at Baird
VOR Vor Biopharma
$20.25 /

-0.68 (-3.25%)

03/25/21 B. Riley
Vor Biopharma initiated with a Buy at B. Riley Securities
03/02/21 Evercore ISI
Vor Biopharma initiated with an Outperform at Evercore ISI
03/02/21 Stifel
Vor Biopharma initiated with a Buy at Stifel
03/02/21 Goldman Sachs
Vor Biopharma initiated with a Sell at Goldman Sachs
VCNX Vaccinex
$2.44 /

+0.08 (+3.39%)

09/25/20 Oppenheimer
Vaccinex price target lowered to $7 from $22 at Oppenheimer
09/22/20 BTIG
Vaccinex downgraded to Neutral from Buy at BTIG
VOR Vor Biopharma
$20.25 /

-0.68 (-3.25%)

VERU Veru
$8.87 /

+0.035 (+0.40%)

VCNX Vaccinex
$2.44 /

+0.08 (+3.39%)

TWST Twist Bioscience
$105.85 /

-1.56 (-1.45%)

SHC Sotera Health
$24.31 /

+0.19 (+0.79%)

PRTA Prothena
$27.44 /

-1.75 (-6.00%)

PHAT Phathom Pharmaceuticals
$35.93 /

+0.755 (+2.15%)

LVTX Lava Therapeutics
$11.00 /

-0.28 (-2.48%)

LABP Landos Biopharma
$11.10 /

+0.1 (+0.91%)

ICLR Icon
$222.66 /

-1.23 (-0.55%)

ICAD iCAD
$16.64 /

+0.18 (+1.09%)

GILD Gilead
$65.31 /

-0.8 (-1.21%)

CRSP Crispr Therapeutics
$115.72 /

-2.52 (-2.13%)

CRIS Curis
$14.43 /

+0.05 (+0.35%)

CABA Cabaletta Bio
$11.06 /

-0.34 (-2.98%)

ADUS Addus HomeCare
$95.64 /

-0.51 (-0.53%)

ACRS Aclaris Therapeutics
$23.64 /

+1.37 (+6.15%)

A Agilent
$137.24 /

-0.9 (-0.65%)

  • 24
    Mar
  • 25
    Mar
  • 18
    Mar
  • 03
    Mar
  • 18
    Feb
  • 05
    Feb
  • 04
    Feb
  • 20
    Jan
  • 17
    Dec
  • 09
    Dec
  • 08
    Dec
  • 03
    Dec
  • 20
    Nov
  • 02
    Oct
  • 13
    Aug
  • 01
    Jul
  • 04
    Jun
ICLR Icon
$222.66 /

-1.23 (-0.55%)

GILD Gilead
$65.31 /

-0.8 (-1.21%)

VERU Veru
$8.87 /

+0.035 (+0.40%)

TWST Twist Bioscience
$105.85 /

-1.56 (-1.45%)

PRTA Prothena
$27.44 /

-1.75 (-6.00%)

PHAT Phathom Pharmaceuticals
$35.93 /

+0.755 (+2.15%)

LVTX Lava Therapeutics
$11.00 /

-0.28 (-2.48%)

LABP Landos Biopharma
$11.10 /

+0.1 (+0.91%)

ICLR Icon
$222.66 /

-1.23 (-0.55%)

ICAD iCAD
$16.64 /

+0.18 (+1.09%)

GILD Gilead
$65.31 /

-0.8 (-1.21%)

CRSP Crispr Therapeutics
$115.72 /

-2.52 (-2.13%)

CRIS Curis
$14.43 /

+0.05 (+0.35%)

ADUS Addus HomeCare
$95.64 /

-0.51 (-0.53%)

ACRS Aclaris Therapeutics
$23.64 /

+1.37 (+6.15%)

A Agilent
$137.24 /

-0.9 (-0.65%)

VERU Veru
$8.87 /

+0.035 (+0.40%)

VCNX Vaccinex
$2.44 /

+0.08 (+3.39%)

SHC Sotera Health
$24.31 /

+0.19 (+0.79%)

GILD Gilead
$65.31 /

-0.8 (-1.21%)

CRSP Crispr Therapeutics
$115.72 /

-2.52 (-2.13%)

CRIS Curis
$14.43 /

+0.05 (+0.35%)

CCCC C4 Therapeutics
$37.38 /

+0.57 (+1.55%)

CABA Cabaletta Bio
$11.06 /

-0.34 (-2.98%)

A Agilent
$137.24 /

-0.9 (-0.65%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.